High expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney proximal tubules of diabetic rats

Advances in Medical Sciences

Volumn 60, Issue 1, 2015, Pages 133-138

  Liu, Fenghua ^a   Yang, Huayu ^a   Chen, Haiping ^a   Zhang, Mi ^a   Ma, Qing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Neutrophil gelatinase associated lipocalin; Proximal tubular injury

Indexed keywords

MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; LIPOCALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; SPRAGUE DAWLEY RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; URINE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY TUBULES, PROXIMAL; LIPOCALINS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84927734358     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2015.01.001     Document Type: Article

References (33)

1. Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 2000;77:S59-66.
2. Ginevri F, Piccotti E, Alinovi R, De Toni T, Biagini C, Chiggeri GM, et al. Reversible tubular proteinuria precedes microalbuminuria and correlates with the metabolic status in diabetic children. Pediatr Nephrol 1993;7(1):23-6.
3. Yaqoob M, McClelland P, Patrick AW, Stevenson A, Mason H, White MC, et al. Evidence of oxidant injury and tubular damage in early diabetic nephropathy. QJM 1994;87(10):601-7.
4. D-glucosaminidase. Kidney Int 2011;79(4):464-70.
5. Li C, Chan YR. Lipocalin 2 regulation and its complex role in inflammation and cancer. Cytokine 2011;56(November (2)):435-41.
6. Lippi G, Cervellin G. Neutrophil gelatinase-associated lipocalin: a more specific assay is needed for diagnosing renal injury. Clin Chim Acta 2012;413(13-14):1160-1.
7. Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr 2011;23(2):194-200.
8. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008;3(3):665-73.
9. Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Investig 2010;120(11):4065-76.
10. Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, et al. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol 2012;11:11.
11. Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C, Simon A, et al. Early urinary and plasma biomarkers for experimental diabetic nephrop-athy. Clin Lab 2012;58(7-8):659-71.
12. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004;286(1): F8-15.
13. Rasch R, Dorup J. Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment. Diabetologia 1997;40(7):802-9.
14. Carev D, Saraga M, Saraga-Babic M. Expression of intermediate filaments, EGF and TGF-alpha in early human kidney development. J Mol Histol 2008;39(2): 227-35.
15. Saad S, Stevens VA, Wassef L, Poronnik P, Kelly DJ, Gilbert RE, et al. High glucose transactivates the EGF receptor and up-regulates serum glucocorti-coid kinase in the proximal tubule. Kidney Int 2005;68(3):985-97.
16. Persson P, Hansell P, Palm F. Tubular reabsorption and diabetes-induced glomerular hyperfiltration. Acta Physiol (Oxf) 2010;200(1):3-10.
17. Mori K1, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from is-chemia-reperfusion injury. J Clin Investig 2005;115(3):610-21.
18. Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, et al. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 2012;41(1):82-8.
19. Lacquaniti A, Donato V, Pintaudi B, Di Vieste G, Chirico V, Buemi A, et al. Normoalbuminuric diabetic nephropathy: tubular damage and NGAL. Acta Diabetol 2013;50(6):935-42.
20. Woo KS, Choi JL, Kim BR, Kim JE, An WS, Han JY. Urinary neutrophil gelatinase-associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease. Diabetes Metab J 2012;36(4):307-13.
21. Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, et al. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract 2012;97(2):251-7.
22. Fu WJ, Li BL, Wang SB, Chen ML, Deng RT, Ye CQ, et al. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res Clin Pract 2012;95(1):105-9.
23. Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH, Rossing P. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 2011;79(10):1113-8.
24. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 2009;75(3):285-94.
25. Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta 2012;1826(1):129-69.
26. Oikonomou KA, Kapsoritakis AN, Theodoridou C, Karangelis D, Germenis A, Stefanidis I, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol 2012; 47(5):519-30.
27. Leclercq A, Houard X, Philippe M, Ollivier V, Sebbag U, Meilhac O, et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 2007;82(6):1420-9.
28. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14(10):2534-43.
29. Arellano-Buendia AS, Garcia-Arroyo FE, Cristobal-Garcia M, Loredo-Mendoza ML, Tapia-Rodriguez E, Sanchez-Lozada LG, et al. Urinary excretion of neutro-phil gelatinase-associated lipocalin in diabetic rats. Oxid Med Cell Longev 2014;2014:1-11. http://dx.doi.org/10.1155/2014/961326. 961326.
30. Togashi Y, Miyamoto Y. Urinary cystatin C as a biomarker for diabetic ne-phropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats. Exp Toxicol Pathol 2013;65(5):615-22.
31. Blazquez-Medela AM, Garcia-Sanchez O, Blanco-Gozalo V, Quiros Y, Montero MJ, Martinez-Salgado C, et al. Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats. PLOS ONE 2014;9(8):e105988.
32. McKittrick IB, Bogaert Y, Nadeau K, Snell-Bergeon J, Hull A, Jiang T, et al. Urinary matrix metalloproteinase activities: biomarkers for plaque angiogen-esis and nephropathy in diabetes. Am J Physiol Renal Physiol 2011; 301(6):F1326-33. http://dx.doi.org/10.1152/ajprenal.00267.2011.
33. Manoli I, Sysol JR, Li L, Houillier P, Garone C, Wang C, et al. Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylma-lonic acidemia. Proc Natl Acad Sci USA 2013;110(33):13552-57.